Impact of Prevention Awareness Group (PAG) on Treatment Attendance and Drug Abstinence Among Substance User

Alcohol Dependence Clinical Trial

Official title:

Impact of Prevention Awareness Group (PAG) on Treatment Attendance and Drug Abstinence Among Substance User: Results of the Randomized Controlled Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02173041
• Other study ID #: Mac/NMP 1216
• Status: Completed
• Phase: N/A
• First received: June 22, 2014
• Last updated: May 15, 2015
• Start date: August 2014
• Est. completion date: April 2015

Study information

• Verified date: May 2015
• Source: Macmillan Research Group UK
• Contact: n/a
• Is FDA regulated: No
• Health authority: India: Indian Council of Medical Research
• Study type: Interventional

Clinical Trial Summary

Substance Use Disorder has been showing a rising trend all over the world including India. The project tested whether a Integrated community wide effort of Prevention and Awareness Groups (PAG) to manage substance use would have a greater effect on treatment attendance and drug abstinence than a de-addiction program alone.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 152
• Est. completion date: April 2015
• Est. primary completion date: March 2015
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• suburban, rural Population

• Drug and/or alcohol dependency (DSM-IV substance use disorders criteria)

Exclusion Criteria:

• Did not consent to participate

• Planning to move or relocate

• Severe mental disorder

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Alcohol Dependence
• Alcoholism
• Drug Dependence,
• Substance Use Disorder
• Substance-Related Disorders

Intervention

Other:
• Prevention Awareness Groups (PAG)

• Standard Care

Locations

Country	Name	City	State
India	GyanSanjeevani	Bai, Nawalgarh	Rajasthan

Sponsors (3)

Lead Sponsor	Collaborator
Macmillan Research Group UK	NMP Medical Research Institute, University of Warwick

Country where clinical trial is conducted

India, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Quality of Life assessed by General Health Questionnaire (GHQ)		Change from baseline to six months	No
Primary	Treatment attendance		Change from baseline to six month	No
Secondary	Drug abstinence		Change from baseline to six month	No